PMWC 2018 Duke Awards
The PMWC Luminary Award recognizes recent contributions of preeminent figures who have accelerated personalized medicine into the clinical marketplace. This year, PMWC 2018 Duke Luminary Award will be honoring Dr. Jeffrey I. Gordon who pioneered the study of gut microbial ecology and evolution and today addresses the global challenges of obesity and undernutrition, and Dr. Mary V. Relling for pioneering and advocating for pharmacogenomic personalized medicine.
Date & Agenda
When: September 24 at 3:30-5:30pm
Agenda: Award Ceremony Agenda
Where: PMWC Venue – Track 1
Suggested dress: Business Attire
Open to attendees only
Past Luminary Award Recipients
Emmanuelle Charpentier
2018
Pioneered the CRISPR-CAS9 Genome Editing Technology
Jennifer Doudna
2017
Pioneered the Groundbreaking Crispr-Cas9 Genome Editing Technology
Edward F. Chang
2017
Pioneer in Human Brain Circuit Mapping to Advance Precision Neuropathology
Roger Perlmutter
2016
Expedited Development of Groundbreaking Therapies
Laura Esserman
2016
Breast Cancer Treatment Paradigm Shifter
Ron Davis
2015
Developed R-loop Technique of Electron Microscopy
Jay Flatley
2014
Established Illumina as the leader in sequence technology
Janet Woodcock
2013
FDA Director, fast-tracked targeted drugs through FDA approval
Brian Druker
2012
Co-inventor, blockbuster drug, Gleevec
George Church
2011
Contributions to the sequencing of genomes and interpreting such data; In Neuroscience he established a “functional connectome”
Lee Hood
2010
Inventions included the automated DNA sequencer and a tool for synthesizing DNA
Past Pioneer Award Recipients
Ronald Levy
2018
Pioneered the concept of antibodies being used as personalized anticancer drugs
Sir John Bell
2018
Leading Genetic and Genomic Research Initiatives that Enable Precision Medicine in the UK and Globally
Alan Ashworth
2018
Co-discovered the BRCA2 gene mutation and made discoveries leading to PARP inhibition in breast and other cancers
James Allison
2017
Pioneered Cancer Immunotherapy Through Discovery of the Immune Checkpoint Blockade
Steve Quake
2017
Steve Quake has pioneered innovative approaches to biological measurement
Irv Weissman
2016
Pioneer in Regenerative Medicine & Cancer Stem Cells
Ralph Snyderman
2016
Widely recognized as “Father of Personalized Medicine”
Craig Venter
2015
1st Draft Human Gen., 1st Complete Diploid Human Gen., and 1st Synth. Bact. Cell
Dennis Lo
2015
Discovered That An Unborn Fetus Releases Fetal DNA Into Maternal Plasma
Jonathan K.C. Knowles
2015 – UK
Personalized Medicine Leader in both Academia and the Pharmaceutical Industry
Yuet Wain Kan
2014
The first to establish that a single DNA mutation could lead to a human disease, and the first to diagnose a human disease by using DNA
Michael Hayden
2014 – Israel
Developer, First Predictive Test for Huntington’s Disease
Kim Popovits
2013 – Israel
Launched both earliest genetically-targeted therapy and molecular diagnostic assay
